Skip to content

Trial on Profermin and Fresubin in Ulcerative Colitis

A Randomized Trial on Profermin and Fresubin for Dietetic Treatment of Active Ulcerative Colitis

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01193894
Acronym
CUPE2
Enrollment
73
Registered
2010-09-02
Start date
2010-08-31
Completion date
2012-12-31
Last updated
2013-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

IBD, UC, Profermin, Fresubin, Probiotics, Dietetic

Brief summary

This study aim to investigate the effect of Profermin versus Fresubin in the dietetic treatment of active ulcerative colitis.

Interventions

Medical Food (food for special medical purposes)

Medical food (food for special medical purposes)

Sponsors

Hvidovre University Hospital
CollaboratorOTHER
Nordisk Rebalance A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Active ulcerative colitis (SCCAI =\>5 and \<=11) * Access to Internet

Exclusion criteria

* Stoma or intestinal resections * Recent changes in UC medication * Treatment with antibiotics * Diabetes * Celiac disease * Lactose malabsorption

Design outcomes

Primary

MeasureTime frameDescription
Development in Simple Clinical Colitis Activity Index (SCCAI) score8 and 16 weeksClinical significant difference (\>1.5) in course of SCCAI score between the two intervention groups

Secondary

MeasureTime frameDescription
Clinical remission8 and 16 weeksProportion of patients in clinical remission (SCCAI=\<2.5)
Safety - Number of Participants with Adverse Events as a Measure of Safety and Tolerability20 weeks
Reduction in SCCAI score8 and 16 weeksProportion of patients with a reduction in SCCAI above 1.5, 3.0 and 4.5

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026